Attached files

file filename
10-K - FOR THE FISCAL YEAR ENDED DECEMBER 31, 2011 - CHINA GEWANG BIOTECHNOLOGY, INC.s32912110k.htm
EX-21 - CHINA GEWANG BIOTECHNOLOGY, INC.ex21.htm
EX-31 - CHINA GEWANG BIOTECHNOLOGY, INC.ex31_1.htm
EXCEL - IDEA: XBRL DOCUMENT - CHINA GEWANG BIOTECHNOLOGY, INC.Financial_Report.xls
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Rich Star Development Corporation (the “Company”) on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Man Yee Kung, Chief Executive Officer (Principal Executive Officer) and Interim Chief Financial Officer (Interim Principal Financial Officer) of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: March 30, 2012
/s/ Man Yee Kung
 
Man Yee Kung
President, Chief Executive Officer (Principal Executive Officer) and Interim Chief Financial Officer (Interim Principal Financial Officer)